MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer

Development of specific serum biomarkers is essential to improve diagnosis and prognosis of non-small cell lung cancer (NSCLC). Here, we show that serum and tissue levels of miR-519d are significantly decreased in NSCLC patients. The low expression of miR-519d is associated with lymph node metastase...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Aili, Zhang, Hongxia, Wang, Jinxiang, Zhang, Shuming, Xu, Zhenyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138586/
https://www.ncbi.nlm.nih.gov/pubmed/32170048
http://dx.doi.org/10.18632/aging.102908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138586/
https://www.ncbi.nlm.nih.gov/pubmed/32170048
http://dx.doi.org/10.18632/aging.102908

Ejemplares similares